ICD 10 code for cannabis dependence

The ICD 10 code for cannabis dependence is used in billing for a condition that is encountered in behavioral health, primary care, and interdisciplinary treatment settings. As cannabis use and legalization continue expanding globally, clinicians increasingly need to understand how this condition is defined, diagnosed, and coded accurately in ICD-10-CM.

Summary

• F12.20 is the ICD 10 code for cannabis dependence without complications. This ICD-10-CM code applies when a person meets criteria for cannabis dependence but does not currently have withdrawal symptoms or cannabis-induced psychiatric or medical conditions.
• Dependence involves loss of control and functional impairment. Core features include compulsive use, unsuccessful attempts to cut down, prioritizing cannabis over responsibilities, and continued use despite negative consequences.
• Accurate documentation and coding support effective treatment and continuity of care. Proper use of the ICD 10 code for cannabis dependence helps ensure clear clinical communication, appropriate referrals, correct reimbursement, and individualized treatment planning. Enrolling in an insurance billing course for therapists can help providers enhance their knowledge.
• Using an EHR like TheraPlatform can significantly streamline tasks like automated invoicing, claim creation, and payment tracking, documentation, scheduling, and client communication

For mental health professionals, including therapists, social workers, and addiction specialists, familiarity with the diagnostic criteria, clinical features, and treatment considerations for cannabis dependence supports precise documentation, safer care, effective treatment planning, and clear communication across care teams.

In the ICD-10-CM (International Classification of Diseases, Tenth Revision, Clinical Modification), cannabis-related disorders fall within F12: Mental and behavioral disorders due to use of cannabinoids.

Within this category, F12.20 specifically denotes Cannabis Dependence, Uncomplicated: a diagnosis that applies when criteria for dependence are met without the presence of physiological complications such as withdrawal or associated psychotic disorders.

Understanding the ICD 10 code for cannabis dependence and closely related codes helps ensure accurate clinical documentation, appropriate treatment referrals, and continuity of care.

Streamline your insurance billing with One EHR

• Claim batching
• Auto claims
• Automated EOB & ERA

• Real-time claim validation
• Real-time claim tracking
• Aging and other reports

Learn More

Definition and clinical context

What is cannabis dependence?

Cannabis dependence is a pattern of cannabis use that leads to clinically significant impairment or distress and is characterized by a cluster of behavioral, cognitive, and physiological symptoms indicating that the individual continues use despite substance-related problems. This pattern reflects loss of control over use, prioritization of cannabis over other activities, and behavioral changes consistent with substance dependence syndrome.

The ICD-10-CM defines dependence as requiring behavioral indicators such as:

• Strong desire or compulsion to use the substance
• Difficulty controlling use
• Continued use despite harm
• Higher priority given to substance use than to other activities
• Evidence of tolerance or withdrawal (although not required for the “uncomplicated” specifier)

The ICD 10 code for cannabis dependence, F12.20, is used when the criteria for dependence are present without physiological complications such as withdrawal or psychotic symptoms. This sets it apart from codes like F12.23 (Cannabis Dependence in withdrawal).

The DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, 5th ed.) uses the term Cannabis Use Disorder with graded severity (mild, moderate, severe) rather than the binary dependence vs. abuse terminology seen in ICD-10-CM, but there is significant overlap in clinical presentation. Mapping between DSM-5 and ICD-10-CM requires careful assessment of symptoms and functional impairment across both frameworks.

Practice Management + EHR + Telehealth

Manage more in less time in your practice with TheraPlatform

Start Free Trial

Criteria and symptoms of cannabis dependence

Core diagnostic features

Cannabis dependence is diagnosed when there is a maladaptive pattern of cannabis use leading to significant impairment or distress, as evidenced by a cluster of symptoms occurring within a 12-month period. The central elements reflect loss of control over use, behavioral changes, and continued use despite negative consequences.

Key clinical features commonly observed in cannabis dependence include:

• Strong craving or urge to use cannabis even when use is inappropriate
• Unsuccessful efforts to cut down or control use, often with repeated relapse
• Increasing priority on cannabis, with a reduction in participation in social, recreational, or occupational activities
• Time spent obtaining, using, or recovering from cannabis use at the expense of other responsibilities
• Continued use despite awareness of persistent or recurrent physical or psychological problems likely caused or exacerbated by cannabis
• Tolerance, where increased amounts are needed to achieve the desired effect

Note: Tolerance may be present, but is not required for the uncomplicated specifier

Although withdrawal, a physiological syndrome following cessation, can occur with cannabis, F12.20 is designated for cases without documented withdrawal. When withdrawal symptoms are present, the correct code is F12.21.

Functional and behavioral signs

Cannabis dependence may manifest in several ways, including:

• Recurrent use in hazardous situations (e.g., driving while impaired)
• Impaired academic or occupational performance
• Neglect of responsibilities or self-care due to use
• Relationship conflicts tied to cannabis use
• Compulsive patterns of obtaining, using, or seeking cannabis

These functional consequences are critical to assess and document, as they drive clinical severity and treatment planning.

Differential assessment

Cannabis dependence must be differentiated from:

• Cannabis abuse / harmful use without dependence features
• Cannabis-induced psychiatric conditions (e.g., psychosis, mood disorders)
• Other substance use disorders or comorbid conditions

Accurate diagnosis requires thorough history-taking, standardized screening tools (e.g., CUDIT-R), collateral reports when available, and clear documentation of symptom onset, course, and functional impact.

Free Resources for Therapists

Click below and help yourself to peer-created resources:

• Ready-to-use worksheets, checklists, assessments & more!
• Master insurance billing with our expert-led course
• Telehealth 101: On-demand videos
• Curious how TheraPlatform solves private practice pain points?

Treatment approaches and therapy goals

Treatment planning for Cannabis Dependence, uncomplicated (F12.20) emphasizes engagement, stabilization, reduction of use, mitigation of harm, and support for behavior change. There is no single universally effective treatment, and care is often individualized based on severity, comorbidity, motivation, and treatment setting.

Initial assessment and engagement

Comprehensive assessment is a foundation for treatment:

• Detailed substance use history
• Assessment of functional impairment
• Identification of comorbid mental health concerns
• Evaluation of motivation to change

Engagement techniques such as motivational interviewing help clients clarify goals, explore ambivalence, and foster readiness for change.

Evidence-based interventions

Although there are no FDA-approved medications specifically for cannabis dependence, psychotherapeutic interventions demonstrate benefit:

Cognitive-Behavioral Therapy (CBT)

CBT focuses on helping individuals:

• Identify and modify triggers and automatic thoughts related to use
• Build coping skills for cravings and high-risk situations
• Develop alternative behaviors that support sobriety goals
• CBT has extensive support in substance use treatment and is adaptable to diverse populations.

Motivational Enhancement Therapy (MET)

MET aims to:

• Increase client motivation for change
• Explore ambivalence about cannabis use
• Strengthen commitment to specific, achievable goals
• Motivation-focused work can precede other therapies to build engagement.

Contingency management

Contingency management uses positive reinforcement for targeted behavior changes (e.g., abstinence, therapy attendance). Evidence supports its utility in promoting short-term abstinence and engagement.

Group and supportive therapies

Peer group support (e.g., relapse prevention groups) adds social accountability and collective learning experiences.

Integrated care and referral

Because cannabis dependence may co-occur with psychiatric disorders, trauma histories, or other substance use disorders, treatment often requires collaborative care:

• Coordination with primary care providers
• Psychiatric evaluation for comorbid mood or anxiety disorders
• Risk assessment for substance interactions

For clients with severe dependence or limited outpatient support, referral to intensive outpatient or residential programs may be appropriate.

Treatment goals

Effective treatment planning may focus on:

• Reducing cannabis use or achieving sustained abstinence
• Enhancing quality of life and functional capacity
• Improving coping strategies for stress and triggers
• Supporting relapse prevention and long-term recovery
• Addressing co-occurring disorders or psychosocial stressors
• Goals should be client-centered, measurable, and revisited regularly.

Practice Management + EHR + Telehealth

Manage more in less time in your practice with TheraPlatform

Start Free Trial

Related ICD-10 codes for cannabis dependence

Accurate differentiation among ICD 10 codes for cannabis dependence is essential for precise documentation and appropriate treatment planning. The F12 category includes multiple specifiers that reflect clinical nuance beyond uncomplicated dependence.

F12.10 – Cannabis abuse, uncomplicated

Used when a problematic pattern of cannabis use leads to impairment or distress but does not meet criteria for dependence.

This code reflects harmful or hazardous use patterns (e.g., legal consequences, impaired functioning, risky behavior) without the hallmark features of dependence, such as loss of control, compulsive use, or prioritization of cannabis over other activities.

Note: Although ICD-10-CM retains the term “abuse,” the DSM-5-TR no longer distinguishes abuse from dependence. Instead, it classifies substance use disorders along a severity continuum (mild, moderate, severe).

F12.21 – Cannabis dependence, in remission

F12.21 is used when an individual previously met criteria for cannabis dependence but no longer meets full criteria, with the exception that craving may still be present.

Remission may be specified as:

• Early remission (at least 3 months but less than 12 months without meeting criteria for dependence)
• Sustained remission (12 months or longer)
• Documentation should clearly indicate:
• A prior diagnosis of cannabis dependence
• Duration of remission
• Current functional status
• Ongoing supports or relapse prevention efforts

This code is appropriate when the focus of treatment involves relapse prevention, recovery maintenance, or monitoring sustained abstinence.

F12.23 – Cannabis dependence with withdrawal

F12.23 applies when criteria for cannabis dependence are met, and the individual is experiencing clinically significant withdrawal symptoms following cessation or reduction of use.

Cannabis withdrawal symptoms may include:

• Irritability or anger
• Anxiety
• Sleep disturbance
• Decreased appetite or weight loss
• Restlessness
• Depressed mood
• Physical symptoms such as abdominal discomfort, tremors, sweating, or headache

Documentation must support:

1. Established cannabis dependence
2. A clear withdrawal syndrome temporally related to reduction or cessation

This code should be used instead of F12.20 when withdrawal is present.

Clinical coding reminder

The term “uncomplicated” does not mean absence of tolerance or physiological adaptation. Tolerance and withdrawal are features of dependence itself.

“Uncomplicated” specifically means that no additional cannabis-induced conditions (e.g., withdrawal, psychotic disorder, mood disorder, delirium, anxiety disorder, or sleep disorder) are documented at the time of diagnosis.

Careful differentiation among these codes ensures diagnostic accuracy, supports appropriate reimbursement, and reflects the clinical reality of the individual’s presentation.

Documentation and best practices

Comprehensive documentation ensures that the clinical picture aligns with diagnostic coding and supports continuity of care across providers.

Key documentation elements

When assigning the ICD 10 code for cannabis dependence, clinicians should document:

• Clear criteria supporting dependence (e.g., loss of control, continued use despite harm)
• Absence of physiological complications like withdrawal
• Functional consequences attributable to cannabis use
• Relevant history, including prior use patterns and attempts to reduce or stop

Example documentation might describe:

“Client reports cannabis use daily for 2+ years, unsuccessful efforts to cut down, priority given to use over work obligations, and continued use despite notable academic and interpersonal problems. No withdrawal symptoms reported.”

Referral and coordination notes

Include notes about:

• Referrals to medical or psychiatric care
• Baseline medical evaluation (e.g., assessment for sleep or mood disturbances)
• Collaboration with primary care or addiction specialists

Precise documentation protects clients and providers by clearly reflecting clinical findings, treatment decisions, and client engagement.

Risk, liability, and ethical considerations

Cannabis dependence, even when “uncomplicated”, is associated with functional impairment, mental health concerns, and life disruption. Failure to recognize and document these patterns may delay care, misinform treatment planning, or impact risk assessment.

Ethically, clinicians should:

• Avoid minimizing the impacts of dependence
• Screen for comorbid disorders
• Ensure treatment goals align with client values and evidence-based practice

Accurate diagnosis and careful documentation also support professional liability protection and service continuity.

The ICD 10 code for cannabis dependence, uncomplicated, is a clinically significant diagnosis that highlights patterns of maladaptive cannabis use, loss of control, and persistent functional consequences.

For behavioral health professionals, understanding this code extends beyond administrative necessity: it reflects clinical clarity, supports treatment planning, and strengthens interdisciplinary communication.

Accurate coding empowers clinicians to document responsibly, advocate for appropriate services, and align diagnostic formulation with client experiences. By recognizing symptoms, differentiating related conditions, and integrating evidence-based interventions, clinicians contribute effectively to comprehensive care for individuals navigating cannabis dependence.

How EHR and practice management software can save you time with insurance billing for therapists

EHRs with integrated billing software and clearing houses, such as TheraPlatform, offer therapists significant advantages in creating an efficient insurance billing process. The key is minimizing the amount of time dedicated to developing, sending, and tracking medical claims through features such as automation and batching. 

What are automation and batching?

• Automation refers to setting up software to perform tasks with limited human interaction.
• Batching or performing administrative tasks in blocks of time at once allows you to perform a task from a single entry point with less clicking.

Which billing and medical claim tasks can be automated and batched through billing software?

• Invoices: Create multiple invoices for multiple clients with a click or two of a button or set up auto-invoice creation, and the software will automatically create invoices for you at the preferred time. You can even have the system automatically send invoices to your clients.
• Credit card processing: Charge multiple clients with a click of a button or set up auto credit card billing, and the billing software will automatically charge the card (easier than swiping!)
• Email payment reminders: Never manually send another reminder email for payment again, or skip this altogether by enabling auto credit card charges.  
• Automated claim creation and submission: Batch multiple claims with one button click or turn auto claim creation and submission on. 
• Live claim validation: The system reviews each claim to catch any human errors before submission, saving you time and reducing rejected claims. 
• Automated payment posting: Streamline posting procedures for paid medical claims with ERA. When insurance offers ERA, all their payments will post automatically on TheraPlatform's EHR.
• Tracking: Track payment and profits, including aging invoices, overdue invoices, transactions, billed services, service providers 

Utilizing billing software integrated with an EHR and practice management software can make storing and sharing billing and insurance easy and save providers time when it comes to insurance billing for therapists.

Streamline your practice with One EHR

• Scheduling
• Flexible notes
• Template library
• Billing & payments

• Insurance claims
• Client portal
• Telehealth
• E-fax

Learn More

Resources for mental health therapists

Theraplatform is an all-in-one EHR, practice management and teletherapy solution with AI-powered notes and Wiley Treatment Planners that allow you to focus more on patient care. With a 30-day free trial, you have the opportunity to experience Theraplatform for yourself with no credit card required. Cancel anytime. They also support different industries including mental and behavioral health therapists in group practices and solo practices.

More resources

• Therapy resources and worksheets
• Therapy private practice courses
• Ultimate teletherapy ebook
• The Ultimate Insurance Billing Guide for Therapists
• The Ultimate Guide to Starting a Private Therapy Practice
• Insurance billing 101
• Practice management tools

Free video classes

• Free on-demand insurance billing for therapist course
• Free mini video lessons to enhance your private practice
• 9 Admin tasks to automate in your private practice

References

American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.; DSM-5-TR). American Psychiatric Association Publishing.

Centers for Disease Control and Prevention & CMS. (2026). ICD-10-CM Official Guidelines for Coding and Reporting.https://stacks.cdc.gov/view/cdc/250974

https://www.cdc.gov/nchs/icd/icd-10-cm/index.html

Hasin, D. S., Saha, T. D., Kerridge, B. T., Goldstein, R. B., Chou, S. P., Zhang, H., Jung, J., Pickering, R. P., Ruan, W. J., Smith, S. M., Huang, B., & Grant, B. F. (2015). Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013. JAMA Psychiatry, 72(12), 1235–1242. https://doi.org/10.1001/jamapsychiatry.2015.1858

National Institute on Drug Abuse (NIDA). (2024). Marijuana Research Report. https://nida.nih.gov/publications/research-reports/marijuana

SUBSTANCE USE DISORDER TREATMENT FOR PEOPLE WITH CO-OCCURRING DISORDERS. (n.d.). https://library.samhsa.gov/sites/default/files/pep20-06-04-006.pdf